The latest bulletin contains information on the following:

• NPSA (from MHRA) : Valproate: organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients
• NPSA (from DHSC): Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba) products
• NPSA (from UKHSA) Potential contamination of some carbomer-containing lubricating eye products with Burkholderia cenocepacia - measures to reduce patient risk
• Emollients and fire risks- Referrals for Safe and Well visits
• MHRA: Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir

• Local shared care guidelines: Riluzole in adult patients
• Bumetanide national shortages: Resources to support prescribers

• SPS: Continuing management of the ADHD medicines shortage
• Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer - updated guidance (CG164)
• Hypertension in adults: diagnosis and management – updated guidance (NG136)
• COVID-19 rapid guideline: managing COVID-19 (update)

Download the bulletin here for more information and links:

• https://cpsc.franktesting.co.uk/download_file/view/4303/2964